Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Alterity Therapeutics Ltd. ( (AU:ATH) ) has provided an announcement.
The Bank of New York Mellon Corporation (BNYMC) has reported a change in its substantial holding in Alterity Therapeutics Ltd., with its voting power decreasing from 33.96% to 24.95%. This shift in voting power could impact BNYMC’s influence over company decisions, potentially affecting Alterity’s strategic direction and stakeholder interests.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. operates in the biotechnology industry, focusing on developing therapeutic products aimed at treating neurodegenerative diseases. The company is primarily engaged in research and development activities to address conditions such as Alzheimer’s and Parkinson’s diseases.
Average Trading Volume: 100
Technical Sentiment Signal: Strong Buy
Current Market Cap: $32.01M
For an in-depth examination of ATH stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue